A comparison of the combination of epinephrine and vasopressin with lipid emulsion in a porcine model of asphyxial cardiac arrest after intravenous injection of bupivacaine

被引:87
作者
Mayr, Viktoria D. [1 ]
Mitterschiffthaler, Lukas [1 ]
Neurauter, Andreas [1 ]
Gritsch, Christian [1 ]
Wenzel, Volker [1 ]
Mueller, Tilko [2 ]
Luckner, Guenter [1 ]
Lindner, Karl H. [1 ]
Strohmenger, Hans-Ulrich [1 ]
机构
[1] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Urol, A-6020 Innsbruck, Austria
关键词
D O I
10.1213/01.ane.0000278866.01963.79
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: In a porcine model, we compared the effect of the combination of vasopressin/epinephrine with that of a lipid emulsion on survival after bupivacaine-induced cardiac arrest. METHODS: After administration of 5 mg/kg of a 0.5% bupivacaine solution IV, ventilation was interrupted for 2 +/- 0.5 (mean +/- SD) min until asystole occurred. Cardiopulmonary resuscitation (CPR) was initiated after I min of untreated cardiac arrest. After 2 min of CPR, 10 animals received, every 5 min, either vasopressin combined with epinephrine or 4 mL/kg of a 20% lipid emulsion. Three minutes after each drug administration, up to three countershocks (4, 4, and 6 J/kg) were administered; all subsequent shocks with 6 J/kg. Blood for determination of the plasma bupivacaine concentration was drawn throughout the experiment. RESULTS: In the vasopressor group, all five pigs survived, whereas none of five pigs in the lipid group had restoration of spontaneous circulation (P < 0.01). There was no significant difference between groups in the plasma concentration of total bupivacaine. CONCLUSION: In this model of a bupivacaine-induced cardiac arrest, the vasopressor combination of vasopressin and epinephrine compared with lipid emulsion resulted in higher coronary perfusion pressure during CPR and survival rates.
引用
收藏
页码:1566 / 1571
页数:6
相关论文
共 44 条
[41]   Comparison between synchronized and non-synchronized ventilation and between guided and non-guided chest compressions during resuscitation in a pediatric animal model after asphyxial cardiac arrest [J].
Manrique, Gema ;
Garcia, Miriam ;
Fernandez, Sarah N. ;
Gonzalez, Rafael ;
Solana, Maria J. ;
Lopez, Jorge ;
Urbano, Javier ;
Lopez-Herce, Jesus .
PLOS ONE, 2019, 14 (07)
[42]   Exposure to Stress-Dose Steroids and Lethal Septic Shock After In-Hospital Cardiac Arrest: Individual Patient Data Reanalysis of Two Prior Randomized Clinical Trials that Evaluated the Vasopressin-Steroids-Epinephrine Combination Versus Epinephrine Alone [J].
Mentzelopoulos, Spyros D. ;
Koliantzaki, Iosifina ;
Karvouniaris, Marios ;
Vrettou, Charikleia ;
Mongardon, Nicolas ;
Karlis, George ;
Makris, Demosthenes ;
Zakynthinos, Epaminondas ;
Sourlas, Sotirios ;
Aloizos, Stavros ;
Xanthos, Theodoros ;
Zakynthinos, Spyros G. .
CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (04) :339-351
[43]   Publisher Correction: Exposure to Stress-Dose Steroids and Lethal Septic Shock After In-Hospital Cardiac Arrest: Individual Patient Data Reanalysis of Two Prior Randomized Clinical Trials that Evaluated the Vasopressin–Steroids–Epinephrine Combination Versus Epinephrine Alone [J].
Spyros D. Mentzelopoulos ;
Iosifina Koliantzaki ;
Marios Karvouniaris ;
Charikleia Vrettou ;
Nicolas Mongardon ;
George Karlis ;
Demosthenes Makris ;
Epaminondas Zakynthinos ;
Sotirios Sourlas ;
Stavros Aloizos ;
Theodoros Xanthos ;
Spyros G. Zakynthinos .
Cardiovascular Drugs and Therapy, 2018, 32 :639-641
[44]   Exposure to Stress-Dose Steroids and Lethal Septic Shock After In-Hospital Cardiac Arrest: Individual Patient Data Reanalysis of Two Prior Randomized Clinical Trials that Evaluated the Vasopressin-Steroids-Epinephrine Combination Versus Epinephrine Alone (vol 32, pg 339, 2018) [J].
Mentzelopoulos, Spyros D. ;
Koliantzaki, Iosifina ;
Karvouniaris, Marios ;
Vrettou, Charikleia ;
Mongardon, Nicolas ;
Karlis, George ;
Makris, Demosthenes ;
Zakynthinos, Epaminondas ;
Sourlas, Sotirios ;
Aloizos, Stavros ;
Xanthos, Theodoros ;
Zakynthinos, Spyros G. .
CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (06) :639-641